Hikma Pharmaceuticals USA INC. recalls

All Hikma Pharmaceuticals USA INC. recalls we track from FDA, CPSC and NHTSA data. Categories: drugs (3).

3 recalls published between August 6, 2025 and September 2, 2026.

• Ramipril Capsules USP, 10 mg, packaged in a) 100 Capsules ( recall
  FDA September 2, 2026 · Hikma Pharmaceuticals USA INC. · Class II
• Alendronate Sodium Oral Solution, 70 mg/75 mL, 75 mL, Rx only… recall
  FDA May 6, 2026 · Hikma Pharmaceuticals USA INC. · Class II
• Lorazepam Injection, USP, 2 mg/mL, 25 x 1mL vials/carton, Rx Only… recall
  FDA August 6, 2025 · Hikma Pharmaceuticals USA INC. · Class II